Puma Biotechnology, Inc. (PBYI) SEC Filings — 2025
8 SEC filings for Puma Biotechnology, Inc. (PBYI) in 2025.
Filings
- Puma Biotech's Q3 Net Income Plunges 56% on Royalty Revenue Drop — 10-Q · Nov 6, 2025
- Puma Biotech Files 10-Q/A, Confirms Accelerated Filer Status — 10-Q/A · Aug 7, 2025
- Puma Biotechnology Changes Fiscal Year End — 8-K · Jun 24, 2025
- Puma Biotechnology Files 8-K on Shareholder Vote Matters — 8-K · Jun 13, 2025
- Puma Biotech Announces Director, Officer, and Compensation Changes — 8-K · May 9, 2025
- Puma Biotech Q1 Loss Widens on Increased R&D — 10-Q · May 8, 2025
- Puma Biotech DEF 14A: Executive Compensation Details — DEF 14A · Apr 28, 2025
- Puma Biotech Reports $362M Revenue, $881M Net Loss for 2024 — 10-K · Feb 27, 2025